Arbutus to Participate in June Investor Conferences
bdtonline.com
news
2022-06-02 11:32:09

WARMINSTER, Pa., June 02, 2022 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that the Company will participate in the following upcoming investor conferences taking place in New York:Jefferies Healthcare Conference (June 8 - 10, 2022) Fireside Chat: 3:00 pm ET on Thursday, June 9, 2022Presenters: Michael McElhaugh, Chief Business Officer; Dr.
